Positive skin test control-histamine - Biologic Drug Details

Summary for positive skin test control-histamine

Tradenames:	2
High Confidence Patents:	0
Applicants:	3
BLAs:	3
Suppliers: see list	2

Note on Biologic Patents

Matching patents to biologic drugs is far more complicated than for small-molecule drugs.

DrugPatentWatch employs three methods to identify biologic patents:

1. Brand-side disclosures in response to biosimilar applications

These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.

2. General brand-side disclosures

These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

3. Patents from broad patent text search

For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

1) High Certainty: US Patents for positive skin test control-histamine Derived from Brand-Side Litigation

No patents found based on brand-side litigation

2) High Certainty: US Patents for positive skin test control-histamine Derived from Company Disclosures

No patents found based on company disclosures

3) Low Certainty: US Patents for positive skin test control-histamine Derived from Patent Text Search

No patents found based on company disclosures

Positive skin test control-histamine Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Positive Skin Test Control-Histamine

Introduction

Positive Skin Test Control-Histamine is a crucial component in the diagnosis of allergies, serving as a positive control to evaluate the skin's reactivity to allergens. This article delves into the market dynamics and financial trajectory of this biologic drug, exploring its usage, market trends, and financial implications.

Clinical Significance and Usage

Role in Allergy Diagnosis

Positive Skin Test Control-Histamine is used as an adjunct in allergy skin tests to diagnose immediate hypersensitivity reactions. It helps in assessing the skin's ability to react to allergens by eliciting a wheal-flare response, which is essential for validating the results of skin tests[1][4].

Administration and Indications

The drug is administered via percutaneous methods such as scratch, prick, or puncture tests. It contains 6.0 mg/mL of histamine base and is indicated for evaluating the skin's reactivity to allergenic extracts[1].

Market Dynamics

Demand and Usage Trends

The demand for Positive Skin Test Control-Histamine is driven by the increasing prevalence of allergic diseases such as hayfever, asthma, and atopic dermatitis. Studies have shown that the number of positive skin tests to a battery of allergens is positively associated with the reported prevalence of these diseases[5].

Competitive Landscape

The market for allergy diagnostic tools is competitive, with several companies producing histamine solutions for skin testing. However, the concentration of histamine used, typically 10 mg/mL as recommended by the EAACI, is a standard that many manufacturers adhere to, ensuring consistency in diagnostic outcomes[4].

Regulatory Environment

The use of Positive Skin Test Control-Histamine is regulated by health authorities, and its administration must be supervised by a physician. Regulatory guidelines ensure that the product meets safety and efficacy standards, which can impact the market dynamics by influencing the availability and pricing of the drug[1].

Financial Trajectory

Revenue Streams

The revenue generated from Positive Skin Test Control-Histamine comes primarily from sales to healthcare providers, hospitals, and allergy clinics. The consistent demand due to the necessity of this product in allergy diagnosis contributes to a stable revenue stream.

Pricing and Cost Factors

The pricing of Positive Skin Test Control-Histamine can vary based on the manufacturer, region, and distribution channels. However, the cost is generally moderate, reflecting the specialized nature of the product and the need for sterile, high-quality solutions. The cost-effectiveness of using histamine as a positive control, compared to other diagnostic methods, also influences its financial trajectory[1].

Market Growth Projections

The market for allergy diagnostic tools, including Positive Skin Test Control-Histamine, is expected to grow due to the increasing incidence of allergic diseases and the expanding healthcare infrastructure. Advances in diagnostic techniques and the integration of histamine skin tests into comprehensive allergy testing protocols further support market growth[5].

Factors Influencing Market Dynamics

Technological Advances

Technological advancements in skin testing devices and methods can influence the market dynamics. For instance, the development of more precise pricking devices and standardized testing protocols can enhance the accuracy and reliability of skin tests, potentially increasing the demand for Positive Skin Test Control-Histamine[4].

Demographic and Environmental Factors

Demographic factors such as age, sex, and ethnicity, as well as environmental factors like exposure to irritants and seasonal changes, can affect skin sensitivity and thus the demand for histamine skin tests. Understanding these factors is crucial for predicting market trends[4].

Economic Factors

Economic conditions, including healthcare spending and insurance coverage, play a significant role in the financial trajectory of Positive Skin Test Control-Histamine. In regions with robust healthcare systems and comprehensive insurance coverage, the demand for this product is likely to be higher[5].

Challenges and Opportunities

Challenges

• Regulatory Compliance: Ensuring compliance with regulatory standards can be a challenge, affecting the availability and pricing of the product.
• Variability in Skin Reactivity: Factors such as age, immunotherapy, and menstrual cycle can influence skin reactivity, which may require adjustments in testing protocols[4].

Opportunities

• Expanding Healthcare Infrastructure: The growth of healthcare infrastructure in emerging markets presents opportunities for increased sales and market expansion.
• Advancements in Diagnostic Techniques: Improvements in skin testing methods and devices can enhance the accuracy and efficiency of allergy diagnosis, increasing the demand for Positive Skin Test Control-Histamine[4].

Key Takeaways

• Essential Diagnostic Tool: Positive Skin Test Control-Histamine is a critical component in allergy diagnosis, ensuring the validity of skin test results.
• Stable Demand: The consistent demand driven by the prevalence of allergic diseases supports a stable revenue stream.
• Regulatory and Technological Influences: Regulatory compliance and technological advancements in skin testing methods are key factors influencing market dynamics.
• Growth Potential: The market for Positive Skin Test Control-Histamine is expected to grow due to increasing healthcare infrastructure and the rising incidence of allergic diseases.

FAQs

What is the primary use of Positive Skin Test Control-Histamine?

Positive Skin Test Control-Histamine is used as a positive control in allergy skin tests to evaluate the skin's reactivity to allergens.

How is Positive Skin Test Control-Histamine administered?

It is administered via percutaneous methods such as scratch, prick, or puncture tests.

What are the common concentrations of histamine used in skin tests?

The common concentration used is 6.0 mg/mL of histamine base, although 10 mg/mL is also recommended by some guidelines[1][4].

What factors influence the demand for Positive Skin Test Control-Histamine?

The demand is influenced by the prevalence of allergic diseases, demographic factors, environmental factors, and advancements in diagnostic techniques.

How does the regulatory environment impact the market for Positive Skin Test Control-Histamine?

Regulatory guidelines ensure safety and efficacy standards, affecting the availability and pricing of the product.

Sources

1. Drugs.com: Positive Skin Test Control - Histamine: Package Insert / Prescribing Info.
2. Koreamed.org: Intradermal Tests for Diagnosis of Drug Allergy are not Affected by a Local Anesthetic.
3. Stanford Profiles: Sayantani Sindher - Stanford Profiles.
4. Karger.com: Histamine and Its Relation to Allergens in the Skin Prick Test.
5. CDC.gov: Percutaneous Immediate Hypersensitivity to Eight Allergens.